Please select the option that best describes you:
In patients with sarcoidosis and persistently elevated liver function tests, when do you consider initiating ursodeoxycholic acid (UDCA)?
Does the degree or pattern of LFT elevation (example: predominant ALK PHOS elevation) influence your decision?